PT 141 nose spray is a needle-free form of bremelanotide studied for sexual desire. Learn how it works, dosing, side effects, and how it compares to injections.
PT 141 nose spray is an intranasal form of bremelanotide, a synthetic peptide that researchers study for low sexual desire. It is not FDA-approved in nasal form, and the only approved bremelanotide product in the United States is Vyleesi, a subcutaneous injection. Nasal versions are sold as research chemicals or prepared by compounding pharmacies, so their dose, purity, and safety are not guaranteed.
What Is PT 141 Nose Spray?
Bremelanotide, also called PT-141, is a melanocortin receptor agonist that acts on the brain rather than on blood vessels. Early studies in the 2000s tested the drug intranasally before the manufacturer switched to an autoinjector for more consistent absorption.
Today, a pt-141 nasal spray is usually a compounded or "research chemical" product rather than a pharmacy-approved medicine. Products marketed this way are not reviewed by the FDA for identity, strength, or sterility, and they are not intended for human consumption.
How PT 141 Nasal Spray Works
Bremelanotide binds to melanocortin 4 receptors in the hypothalamus, a brain region involved in regulating sexual desire. This mechanism differs from PDE5 inhibitors such as sildenafil, which improve blood flow but do not directly target desire.
Because the drug works on central arousal pathways, it is discussed mainly for hypoactive sexual desire disorder (HSDD) in premenopausal women. Some men use it off-label for libido, but the clinical evidence in men is limited.
Bremelanotide does not appear to work like a hormone. It does not raise testosterone, and it is not a treatment for erectile dysfunction on its own.
PT 141 Nasal Spray vs Injection
The two delivery methods differ in approval status, dose accuracy, and how quickly the drug reaches the bloodstream. The table below summarizes the main differences.
| Feature | Nasal spray (compounded or research) | Vyleesi injection (FDA-approved) |
|---|---|---|
| FDA approval | Not approved | Approved for premenopausal women with HSDD |
| Dose form | Liquid nasal spray | 1.75 mg prefilled autoinjector |
| Typical onset | Often reported at 30-60 minutes, highly variable | About 45 minutes |
| Absorption | Inconsistent between people and batches | Consistent and predictable |
| Common side effects | Nasal irritation, nausea, flushing, headache | Nausea, flushing, headache, injection site reactions |
| Access | Online research sites or compounding pharmacies | Prescription only |
Vyleesi delivers 1.75 mg under the skin and is used at least 45 minutes before anticipated sexual activity. The labeled maximum is one dose in 24 hours and no more than eight doses per month.
Nasal absorption varies widely, so it is hard to predict how much drug actually reaches the bloodstream. When researchers compare pt-141 nasal spray vs injection, the injection consistently produces more reliable blood levels.
Dosing and How to Use PT 141 Nasal Spray
There is no standard dose for PT 141 nose spray because no nasal product has been approved. Compounded sprays are prepared at different concentrations, and a spray from one pharmacy may deliver far more or less peptide than a spray from another.
Instructions online about how to make pt-141 nasal spray usually involve mixing lyophilized peptide with bacteriostatic water and transferring it into a spray bottle. That approach carries real risks, including incorrect concentration, bacterial contamination, and no way to confirm the raw peptide's identity or purity.
If a clinician does prescribe a compounded nasal spray, general steps for how to use pt-141 nasal spray include:
- Wash your hands and gently blow your nose before each dose.
- Prime the pump if the bottle is new or has not been used recently.
- Keep your head upright, insert the tip, and breathe in gently through the nose while spraying.
- Avoid blowing your nose for a few minutes afterward so the solution stays in contact with the lining.
- Record the time, dose, and any side effects so your clinician can adjust the plan.
Do not combine nasal bremelanotide with other libido or erectile medications without medical guidance.
Side Effects and Safety
Nausea is the most commonly reported side effect of bremelanotide, and it is often the reason people stop using it. Other effects include flushing, headache, and nasal irritation or a runny nose with the spray form.
Bremelanotide can cause short-term changes in blood pressure, so it is contraindicated in people with uncontrolled hypertension or known cardiovascular disease. Repeated use has also been linked to hyperpigmentation, a darkening of the skin, gums, or other areas.
Bremelanotide is a prescription drug in its approved injectable form, and anyone considering a nasal version should talk with a healthcare professional first. Pregnant or breastfeeding women should not use it.
Reading PT 141 Peptide Nasal Spray Reviews
Many pt-141 peptide nasal spray reviews online describe dramatic results, but customer testimonials and forum posts are not clinical evidence. Vendor reviews can be bought or written by people who never used the product.
Look instead for a third-party certificate of analysis (COA) that lists peptide purity, tested mass, and the laboratory that ran the test. A COA does not prove a product is safe for human use, but its absence is a clear warning sign.
Common red flags include prices far below the market, claims of "no side effects," no dosing information, and pressure to buy in bulk.
Frequently Asked Questions
Below are answers to the questions people ask most about intranasal bremelanotide.
The Bottom Line
PT 141 nose spray offers needle-free convenience, but it is unapproved, inconsistently absorbed, and often sold without quality oversight. The FDA-approved option remains the Vyleesi injection, which delivers a fixed 1.75 mg dose and has a known safety profile.
If low sexual desire is affecting your life, a clinician can help you weigh the risks and benefits of approved treatments. Bremelanotide is not a cure for relationship issues, low testosterone, or other underlying causes of low libido.
Frequently Asked Questions
Is PT 141 nose spray FDA-approved?
No. The FDA has not approved any nasal bremelanotide product for human use in the United States. The only approved bremelanotide medicine is Vyleesi, a 1.75 mg subcutaneous injection prescribed for premenopausal women with acquired, generalized hypoactive sexual desire disorder.
How long does PT 141 nose spray take to work?
Reported onset varies. The approved injection is typically used about 45 minutes before sexual activity, and nasal users often report effects within 30 to 60 minutes, though absorption through the nose is unpredictable. Effects generally last a few hours.
Where can you buy PT 141 nasal spray?
Nasal bremelanotide is not sold as an approved pharmacy product. Some online vendors market it as a research chemical, and compounding pharmacies may prepare it with a prescription, but dosing and quality are not standardized. Research chemicals are not intended for human consumption.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.